These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1389 related items for PubMed ID: 9485189

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
    Costello RT, Mallet F, Chambost H, Sainty D, Gastaut JA, Olive D.
    Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
    [Abstract] [Full Text] [Related]

  • 3. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
    Fujihara M, Takahashi TA, Azuma M, Ogiso C, Maekawa TL, Yagita H, Okumura K, Sekiguchi S.
    Blood; 1996 Mar 15; 87(6):2386-93. PubMed ID: 8630402
    [Abstract] [Full Text] [Related]

  • 4. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
    Jaiswal AI, Dubey C, Swain SL, Croft M.
    Int Immunol; 1996 Feb 15; 8(2):275-85. PubMed ID: 8671613
    [Abstract] [Full Text] [Related]

  • 5. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L, Plumas J, Jacob MC, Bost F, Molens JP, Sotto JJ, Bensa JC.
    Exp Hematol; 1999 Mar 15; 27(3):479-88. PubMed ID: 10089910
    [Abstract] [Full Text] [Related]

  • 6. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW, Vermeiren J, Rafiq K, Lorr K, de Boer M, Ceuppens JL.
    Eur J Immunol; 1999 Aug 15; 29(8):2367-75. PubMed ID: 10458748
    [Abstract] [Full Text] [Related]

  • 7. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
    Nieland JD, Kruisbeek AM.
    Int Immunol; 1995 Nov 15; 7(11):1827-38. PubMed ID: 8580081
    [Abstract] [Full Text] [Related]

  • 8. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    J Exp Clin Cancer Res; 1998 Sep 15; 17(3):251-8. PubMed ID: 9894758
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission.
    Whiteway A, Corbett T, Anderson R, Macdonald I, Prentice HG.
    Br J Haematol; 2003 Feb 15; 120(3):442-51. PubMed ID: 12580958
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes.
    Vecchiarelli A, Monari C, Retini C, Pietrella D, Palazzetti B, Pitzurra L, Casadevall A.
    Eur J Immunol; 1998 Jan 15; 28(1):114-21. PubMed ID: 9485191
    [Abstract] [Full Text] [Related]

  • 13. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
    Lumsden JM, Williams JA, Hodes RJ.
    J Immunol; 2003 Jan 15; 170(2):781-7. PubMed ID: 12517941
    [Abstract] [Full Text] [Related]

  • 14. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
    Fleischer J, Soeth E, Reiling N, Grage-Griebenow E, Flad HD, Ernst M.
    Immunology; 1996 Dec 15; 89(4):592-8. PubMed ID: 9014827
    [Abstract] [Full Text] [Related]

  • 15. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD, Starling GC, Williams LA, Hock BD, Hart DN.
    Eur J Immunol; 1995 Jul 15; 25(7):2064-8. PubMed ID: 7542604
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
    Ranheim EA, Kipps TJ.
    J Exp Med; 1993 Apr 01; 177(4):925-35. PubMed ID: 7681471
    [Abstract] [Full Text] [Related]

  • 18. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L, Perin A, Siviero M, Piazza F, Facco M, Gurrieri C, Galvan S, Adami F, Agostini C, Pizzolo G, Zambello R, Semenzato G.
    Cancer; 2000 Sep 15; 89(6):1259-68. PubMed ID: 11002221
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
    Soos JM, Ashley TA, Morrow J, Patarroyo JC, Szente BE, Zamvil SS.
    Int Immunol; 1999 Jul 15; 11(7):1169-79. PubMed ID: 10383950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.